Bridge Biotherapeutics Inc.
Bridge Biotherapeutics Inc., based in the Republic of Korea, US, and China, is a publicly-traded clinical-stage biotech company founded in 2015. Bridge Biotherapeutics is engaged in the discovery and development of novel therapeutics, focusing on therapeutic areas with high unmet needs such as ulcerative colitis, fibrotic diseases, and cancers. Science & Technology
Economy
Subscribers
606
Videos
78
Country
Korea
Join Date
2018-09-14
Channel
Size
NanoGraphite
Link
You can find the most up-to-date quantitative data in the above tabs.
Channel Briefing
Channel Overview
Content Style
Fandom & Brand Safety
Advertising Strategy
Performance
Channel Overview
Hang tight — We’re summarizing this channel with fresh, up-to-date data.
We’ll notify you when the summary is ready — it usually takes 1–2 minutes.